Mesa Laboratories, Inc.
MLAB
$93.39
$2.192.40%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 7.23% | 2.01% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 7.23% | 2.01% | |||
| Cost of Revenue | -0.32% | 3.55% | |||
| Gross Profit | 11.96% | 1.06% | |||
| SG&A Expenses | 4.47% | -4.61% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.03% | -0.83% | |||
| Operating Income | 68.82% | 54.18% | |||
| Income Before Tax | 129.91% | -71.49% | |||
| Income Tax Expenses | 302.52% | -121.01% | |||
| Earnings from Continuing Operations | 46.61% | -47.79% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 46.61% | -47.79% | |||
| EBIT | 68.82% | 54.18% | |||
| EBITDA | 29.48% | 17.20% | |||
| EPS Basic | 46.08% | -48.23% | |||
| Normalized Basic EPS | 129.07% | -71.73% | |||
| EPS Diluted | 44.70% | -47.15% | |||
| Normalized Diluted EPS | 128.71% | -71.40% | |||
| Average Basic Shares Outstanding | 0.36% | 0.86% | |||
| Average Diluted Shares Outstanding | 0.54% | -0.32% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -0.32% | 0.93% | |||